Skip to content

Effectiveness and cost-effectiveness of Korean and Western medicine collaborative treatment for Low Back Pain - a prospective observational study

Effectiveness and cost-effectiveness of Korean and Western medicine collaborative treatment for Low Back Pain - A prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002827
Enrollment
360
Registered
2018-04-24
Start date
2018-04-20
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dunsan Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults (19 years old or older) 2. Among the first patients (19 years old or older) of Pilot business organization, the primary symptom is 'low back pain'. 3. any person who has decided to participate in this clinical study as his/her own or a legal representative and has signed the consent form.

Exclusion criteria

Exclusion criteria: 1. Any person participating in other clinical trials (not applicable to those participating in observational studies) 2. Any person who is expected to be difficult to comply with the clinical research schedule. 3. Any person who is expected to have difficulty understanding and responding to research questionnaires, such as illiteracy and lack of body and mind 4. Any person with difficulties in clinical research

Design outcomes

Primary

MeasureTime frame
Effectiveness Evaluation-Numeric Rating Scale;Effectiveness Evaluation-Oswestry Disability Index;Effectiveness Evaluation-Recovery Status;Effectiveness Evaluation - EQ-5Dimension-5Line and EQ-Visual Analog Scale

Secondary

MeasureTime frame
Cost-effective Assessment - Cost per QALYs(Quality Adjusted Life Years);Cost-effective Assessment - Incremental Cost-Effectiveness Ratio(ICER);Cost-effective Assessment - Incremental Net Benefit;Cost-effective Assessment - Cost-Effectiveness Acceptability Curve

Countries

Korea, Republic of

Contacts

Public ContactKIM IK

Dunsan Korean Medicine Hospital of Daejeon University

kjik91@naver.com+82-42-470-9764

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 23, 2026